Latest updates on the coronavirus and heart disease
5 March 2020, Geneva/Cape Town
The novel coronavirus (COVID-19) epidemic started late December in Wuhan City, Hubei Province, China, and has since spread to 87 countries and territories in the world. Poor regions haven’t been spared and the need for a context-specific response has become urgent. Large and densely populated areas with widespread poverty and high migration are more vulnerable to airborne pandemics. As a global organization representing the cardiovascular community, WHF is committed to offering the latest evidence of the COVID-19 outbreak. With over 200 Members worldwide, we want to ensure that everyone, especially those living in poorer areas, is aware of the necessary measures to protect themselves and others.
As of today, 5 March 2020, there are 22 cases in 7 African countries: Algeria, Egypt, Tunisia, Morocco, Nigeria, South Africa, and Senegal. “A significant part of the population in the continent is already extremely vulnerable”, says Professor Karen Sliwa, WHF President. “Hundreds of millions of people there are affected by HIV/AIDS, tuberculosis or malaria. The vastly spreading COVID-19 can thus lead to an even greater number of deaths and suffering. In addition, non-communicable diseases (NCDs), and specifically chronic obstructive pulmonary disease (COPD), heart disease, hypertension and diabetes are major risk factors for developing severe symptoms of COVID-19.”
We are concerned that previous studies on other coronavirus diseases such as SARS-CoV and MERS-CoV have demonstrated a relationship between CVD, diabetes and increased morbidity and mortality due to coronavirus disease. Considering the greater risk for populations in impoverished settings, WHF has developed the following guidelines on COVID-19 prevention and control in low-income countries.
Research suggests than individuals with pre-existing medical conditions, such as diabetes and heart disease, as well as those who live in poor and densely populated areas, are more vulnerable to the worst outcomes of the virus. For people with chronic respiratory disease (e.g. chronic obstructive airways disease), infectious diseases (e.g. HIV and tuberculosis), chronic cardiovascular disease (e.g. cardiomyopathy, previous myocardial infarction, rheumatic heart disease), cancer or autoimmune diseases, Prof. Karen Sliwa and experts from WHF, including Prof. Friedrich Thienemann, Prof. Junbo Ge, Prof. Rick Grobbee and Prof. Fausto Pinto, recommend:
If COVID-19 spreads extensively in low-income countries, containment may not be realistic and response efforts will likely need to transition to various mitigation strategies, which could include isolating ill people at home and closing schools, universities, places of religious worship and public events.
As stated by the World Health Organization (WHO), coronaviruses belong to a family of viruses that can cause mild disease such as a common cold, but also severe respiratory disease such as Middle East Respiratory Syndrome (MERS-CoV) or Severe Acute Respiratory Syndrome (SARS-CoV). The novel coronavirus epidemic Coronavirus Disease 2019 (COVID-19) is caused by a coronavirus named SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2).
SARS-CoV-2 is transmitted from animals to people and was first isolated from patients with pneumonia in Wuhan, China. The spread from human-to-human occurs via aerosol transmission — coughing and sneezing. Respiratory droplets containing the virus may contaminate surfaces up to 96 hours, for instance, screens of smartphones.
Signs of COVID-19 can include flu-like symptoms such as fever, cough, fatigue, headache and sore throat. The virus can lead to pneumonia, severe acute respiratory syndrome or breathing difficulties and, in more severe cases, be fatal.
For additional information, we encourage you to monitor the updates of the World Health Organization. For other enquiries, please contact us at email@example.com.
ACC.20/WCC Virtual: WHF President Prof Karen Sliwa Opening Remarks
Call for papers: submit your research on COVID-19 and CVD
WHF President Prof Karen Sliwa's message on COVID-19